Can Modern Pharmacy Keep Up with Telehealth and Personalized Medicine? with Christian Stella

In this episode of Compounding Interest: The Business of Personalized Medicine, host Amy Summers sits down with fourth-generation pharmacist Christian Stella to explore how compounding has evolved from the neighborhood pharmacies of the early 1900s into a technology-enabled industry serving telehealth companies and patients at scale. Christian draws parallels between the pharmaceutical industrialization his great-grandfather experienced and today's convergence of telehealth, personalized medicine, GLP-1 therapies, changing regulations, and new fulfillment models. Christian Stella is a PharmD, fourth-generation pharmacist, and CEO of Precision Medicine. Pharmacy has been part of Christian's life from the beginning. He grew up around his family's pharmacies, progressing from stocking shelves and making neighborhood deliveries to attending pharmacy school and eventually building a compounding operation of his own. Today, his focus includes scalable pharmacy infrastructure, technology integrations, quality and compliance, personalized formulations, innovative dosage forms, and long-term partnerships with telehealth companies. **Expect to Learn** - How compounding pharmacy is evolving alongside telehealth, personalized medicine, and changing patient expectations. - What telehealth companies need from pharmacy partners to deliver medications efficiently at scale. - Why quality and compliance must remain central as a compounding pharmacy grows. - How long-term risk shaped Precision Medicine’s decision to step away from GLP-1 compounding. - Why saying no to certain revenue opportunities can create room for innovation and sustainable growth. **Timestamps** \[00:00] - Episode Teaser \[01:10] - Four Generations of Pharmacy \[02:33] - Why Compounding Pharmacy Is Changing Again \[05:38] - Growing Up in the Family Pharmacy \[07:39] - Building the “Garage Band” of Compounding Pharmacy \[10:31] - Building Pharmacy Infrastructure for Telehealth \[17:42] - Scaling Without Sacrificing Quality or Compliance \[19:21] - Evaluating Telehealth Partners Like Investments \[21:40] - Walking Away From the GLP-1 Opportunity \[26:30] - Diversification and Dosage-Form Innovation \[38:21] - Quality, Necessary Endings, and Preparing for California **Follow Christian Stella:** - **LinkedIn:** https://www.linkedin.com/in/christianstellaprecision/ - **Website (Company):** https://precisionmeds.com/ - **LinkedIn (Company):** https://www.linkedin.com/company/precisionmedicine211/home/ - **Facebook (Company):** https://www.facebook.com/precisionmedicine1/ **Follow the Host:** - **Amy Summers:** https://www.linkedin.com/in/amy-summers-pharmd-bcscp-fapc-20b04a93/ - **Restore Health Consulting:** https://www.restorehealthconsulting.com/ **Follow The Podcast:** - **YouTube:** https://www.youtube.com/@RestoreHealthConsulting - **Spotify:** https://open.spotify.com/show/033F4FRUbjSrN1oNbfozhD?si=caf30ccfd2ba49b6 - **Apple Podcasts:** https://podcasts.apple.com/in/podcast/compounding-interest/id6784679391 **"Disclosure:** Portions of this episode (such as the introduction or promotional segments) use AI-generated voice narration produced under human editorial review."